N/A N=93 Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment
Esophageal Lesion
Primary: Number of Participants With Esophageal Lesions Identified Using Capsule Endoscopy — 15 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=25 Evaluation of PillCam® Express Capsule Endoscopy Delivery System
Small Bowel Disease · Inflammatory Bowel Disease
Primary: Number of Participants With Successful Capsule Placement Into the Duodenum Using Capsule Delivery System — 25 participants
N/A N=24 Capsule Endoscopy for HEmorrhage in the ER
Upper Gastrointestinal Bleeding
Primary: Number of Participants Discharged for Outpatient Management of Upper GI Bleeds — 3; 9 Participants
N/A N=45 Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children
IBD
Primary: Diagnostic Yield of Magnetic Resonance Enterography (MRE) — 52 % Percentage of Diagnostic yeild
N/A N=35 Study of Early Endocapsule (EC) in Clinical Decision Unit Versus Standard of Care Work-up for GI Bleeding
Gastro Intestinal Bleeding · Hematemesis · Melena
Primary: Rate of Detection of Bleeding — 11; 11 Participants
N/A N=98 Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease
Crohn's Disease
Primary: Diagnostic Yield in Suspected Crohn's Patients (CE Prior to IC vs. IC and SBFT) — 97.3; 57.3 percentage of yield — p=<0.0001
N/A N=30 Evaluation of Capsule Endoscopy With PillCam® Colon 2 in Visualization of the Colon
Colorectal Lesions
Primary: Accuracy of the PillCam® Colon 2 Capsule Endoscopy (CE) for Polyps Per Subject - Sensitivity — 83; 50 percentage of sensitivity
Phase 3 N=332 PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon
Colonic Diseases
Primary: Number of Participants With Successful Capsule Endoscopies or Standard Colonoscopies — 322; 326 participants
N/A N=884 Evaluation of Capsule Endoscopy With PillCam® COLON 2 in Visualization of the Colon
CRC Screening
Primary: Sensitivity and Specificity of PillCam Platform With the PillCam COLON 2 Capsule in Detecting Patients With Polyps ≥6 mm Where OC Considered as the Gold Standard…
N/A N=121 Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease
Intestinal Disease · Inflammatory Bowel Disease · Crohn Disease
Primary: Normal vs Abnormal, Overall Impression — 42; 42; 72; 72 participants — p=1.0000
N/A N=25 Detachable String Magnetically Controlled Capsule Endoscopy for Completely Viewing of Esophagus and Stomach
Outpatients
Primary: Number of Participants With Successful Separation of Capsule and String, and Complete Viewing of Esophagus and Stomach — 25 Participants
Phase 2 N=75 PillCam® Platform With the PillCam Crohn's Disease Capsule
Crohn's Disease
Primary: Per-subject Diagnostic Yield of the PillCam Platform With the CD Capsule Within the Terminal Ileum and Colon as Compared to the Ileocolonoscopy Diagnostic Yield Within…
N/A N=87 Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding
Melena · Gastrointestinal Hemorrhage
Primary: Time to Localization of Bleeding — 21; 16 hours — p=.002
N/A N=225 PillCam SB3 Capsule- Feasibility Study
Small/Large Bowel
Primary: Precentage of SB3 Images That Were Graded as Superior in Image Quality to SB2 by the Physicians — 98 percentage of cases
N/A N=320 Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Colorectal Cancer Screening
Primary: Number of Participants With an Actionable Lesion on CCE vs. CTC Confirmed by Optical Colonoscopy — 34; 11 Participants
N/A N=57 SB3 Battery Life Observational Study
Capsule Endoscopy
Primary: Completion Rate (Rate at Which Small Bowel is Completely Examined) — 57 Participants
N/A N=10 Study of the Feasibility of Magnetic Navigated Capsule Endoscope in the Upper Gastrointestinal Tract Examination
Healthy Patient on Good Condition
Primary: Assess the Completeness of Capsule Endoscopy — 100; 85.2; 86.1 percentage of mucosa visibility
N/A N=20 Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility
Gastroparesis · Dyspepsia
Primary: Frequency of Contractions at Baseline — 20; 24.6; 23.7 stomach contractions/minute
N/A N=74 Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects
Known Crohn Disease Subjects
Primary: Mucosal Change in VCE (Video Capsule Endoscopy) Mucosal Scores and PGA (Physician Global Assessment) — -0.3; -382.9; -2.7 units on a scale — p=0.631
N/A N=50 Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices
Esophageal Varices
Primary: Aerosol-generating Amount — 8195; 0; 13296; 1483 Particles generated
N/A N=131 PillSense System for Detecting UGI Bleed
UGI Bleed · Upper Gastrointestinal Bleeding · Upper Gastrointestinal Bleed
Primary: Sensitivity — 26 Participants
N/A N=3 Pilot Study to Image the Esophagus Using a SECM Tethered Endoscopic Capsule
Healthy · Barrett's Esophagus · Gastric Acid Reflux
Primary: Feasibility for Imaging of Esophagus Using an SECM Tethered Endoscopic Capsule. — 3 Participants
N/A N=43 MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)
Abdominal Pain · Gastritis · Gastric Ulcer
Primary: Number of Participants With Visualization of All Major Anatomic Regions in the Stomach With MCCE Based on 2 Reviewers — 37; 39; 39; 36 participants
Phase 4 N=5 Study of Metoclopramide in Small Bowel Capsule Endoscopy
Pill Capsule Endoscopy Completion Rates
Primary: Difference in Treatment vs. Placebo in Pill Capsule Completion Rates — 100; 0; 100 percentage of complete capsule studies
N/A N=158 Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.
Crohn Disease
Primary: Accuracy of CE Versus IC Plus MRE for Detecting Active Crohn's Disease (CD), by Visualizing the Small Bowel and Colon in Subjects With Know CD and Mucosal Disease. — 94…
Phase 4 N=23 Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®
Gastrointestinal Lesions · Signs and Symptoms, Digestive
Primary: GI Mucosal Lesions Change and Clinical Symptoms Using The Gastrointestinal Symptom Rating Scale (GSRS) Score — 2.99; 2.19 GSRS score — p=0.05
N/A N=60 Pilot Study for Imaging of the Esophagus Using a Tethered Capsule OCT Endomicroscopy in the Primary Care Setting
Healthy
Primary: Feasibility of Esophageal Imaging in Subjects Who Successfully Swallow the OCT Capsule in the Primary Care Setting. — 45 Participants
N/A N=4 Pilot Study for Imaging of the Esophagus Using Tethered Capsule OCT Endomicroscopy With Distal Scanning
Healthy
Primary: Number of Participants For Whom Good Quality Images Were Recorded After Swallowing The OFDI Capsule — 3 Participants
N/A N=5 Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE)
Colonoscopy
Primary: MFE Navigation to the Cecum From the Rectum in Less Than 40 Minutes — 0 Participants
N/A N=56 Study to Image the Esophagus Using the OFDI Capsule
Barrett's Esophagus · Eosinophilic Esophagitis
Primary: Feasibility of OFDI Imaging in Subjects Swallowing the OFDI Capsule — 56 Participants